Protagonist Therapeutics, Inc. (PTGX) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Protagonist Therapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -42.66x | 8.64x | -16.49x | -4.20x | -12.62x | -10.48x |
| P/B Ratio | 9.03x | 3.52x | 3.87x | 2.48x | 5.28x | 2.48x |
| P/S Ratio | 120.66x | 5.47x | 21.69x | 20.13x | 57.91x | 24.22x |
| Profitability | ||||||
| Gross Margin | 97.3% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating Margin | -343.6% | 58.2% | -156.1% | -494.2% | -460.0% | -225.4% |
| Net Margin | -282.8% | 63.3% | -131.6% | -479.3% | -458.9% | -231.1% |
| EBITDA Margin | -278.4% | 58.4% | -150.6% | -481.6% | -449.9% | -222.0% |
| Liquidity | ||||||
| Current Ratio | 12.71x | 12.48x | 16.71x | 7.80x | 7.74x | 7.84x |
| Quick Ratio | 12.71x | 12.48x | 16.71x | 7.80x | 7.74x | 7.84x |
| Leverage | ||||||
| Debt/Equity | 0.02x | 0.02x | 0.00x | 0.02x | 0.02x | 0.02x |
YoY = year-over-year change. Source: FMP..